Synthesis, kinetic studies and <i>in-silico</i> investigations of novel quinolinyl-iminothiazolines as alkaline phosphatase inhibitors
作者:Muhammad Naeem Mustafa、Pervaiz Ali Channar、Muhammad Sarfraz、Aamer Saeed、Syeda Abida Ejaz、Mubashir Aziz、Fatmah Ali Alasmary、Hanadi Yaqob Alsoqair、Hussain Raza、Song Ja Kim、Asad Hamad
DOI:10.1080/14756366.2022.2163394
日期:2023.12.31
maximum alkaline phosphatase inhibitory effect (IC50 = 0.337 ± 0.015 µM) as compared to other analogues and standard KH2PO4 (IC50 = 5.245 ± 0.477 µM). The results were supported by the molecular docking studies, molecular dynamics simulations and kinetic analysis which also revealed the inhibitory potential of compound N-benzamide quinolinyl iminothiazoline (6g) against alkaline phosphatase. This compound
摘要 羟基磷灰石(HA)或碱性磷酸盐晶体在软组织上的沉积引起病理性钙化疾病,包括终末期骨关节炎(OA)、强直性脊柱炎(AS)、内侧动脉钙化和肿瘤钙化。病理性钙化表现为组织非特异性碱性磷酸酶 (TNAP) 浓度增加。需要一种有效的治疗策略来根除这些疾病,为此碱性磷酸酶抑制剂可以发挥潜在作用。在此背景下,合成了一系列新型喹啉基亚氨基噻唑啉并评估了碱性磷酸酶抑制潜力。对所有化合物进行 DFT 研究,其中N -苯甲酰胺喹啉基亚氨基噻唑啉 ( 6g )、N-二氯苯甲酰胺喹啉基亚氨基噻唑啉 ( 6i ) 和N-硝基苯甲酰胺喹啉基亚氨基噻唑啉 ( 6j ) 被发现是最具反应性的化合物。然后在体外测试期间,与其他类似物和标准 KH 2 PO 4 (IC 50 = 5.245 ) 相比,化合物N-苯甲酰胺喹啉基亚氨基噻唑啉 ( 6g ) 表现出最大的碱性磷酸酶抑制作用 (IC 50 = 0.337 ± 0.015